Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
27.05
+0.44 (1.65%)
At close: Mar 6, 2026, 4:00 PM EST
26.93
-0.12 (-0.44%)
After-hours: Mar 6, 2026, 7:59 PM EST
Pfizer Employees
Pfizer had 75,000 employees as of December 31, 2025. The number of employees decreased by 6,000 or -7.41% compared to the previous year.
Employees
75,000
Change (1Y)
-6,000
Growth (1Y)
-7.41%
Revenue / Employee
$834,387
Profits / Employee
$103,613
Market Cap
153.81B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 75,000 | -6,000 | -7.41% |
| Dec 31, 2024 | 81,000 | -7,000 | -7.95% |
| Dec 31, 2023 | 88,000 | 5,000 | 6.02% |
| Dec 31, 2022 | 83,000 | 4,000 | 5.06% |
| Dec 31, 2021 | 79,000 | 500 | 0.64% |
| Dec 31, 2020 | 78,500 | -9,800 | -11.10% |
| Dec 31, 2019 | 88,300 | -4,100 | -4.44% |
| Dec 31, 2018 | 92,400 | 2,200 | 2.44% |
| Dec 31, 2017 | 90,200 | -6,300 | -6.53% |
| Dec 31, 2016 | 96,500 | -1,400 | -1.43% |
| Dec 31, 2015 | 97,900 | 19,600 | 25.03% |
| Dec 31, 2014 | 78,300 | 600 | 0.77% |
| Dec 31, 2013 | 77,700 | -13,800 | -15.08% |
| Dec 31, 2012 | 91,500 | -12,200 | -11.76% |
| Dec 31, 2011 | 103,700 | -6,900 | -6.24% |
| Dec 31, 2010 | 110,600 | -5,900 | -5.06% |
| Dec 31, 2009 | 116,500 | 34,700 | 42.42% |
| Dec 31, 2008 | 81,800 | -4,800 | -5.54% |
| Dec 31, 2007 | 86,600 | -11,400 | -11.63% |
| Dec 31, 2006 | 98,000 | -8,000 | -7.55% |
| Dec 31, 2005 | 106,000 | -9,000 | -7.83% |
| Dec 31, 2004 | 115,000 | -7,000 | -5.74% |
| Dec 31, 2003 | 122,000 | 24,000 | 24.49% |
| Dec 31, 2002 | 98,000 | 8,000 | 8.89% |
| Dec 31, 2001 | 90,000 | 0 | - |
| Dec 31, 2000 | 90,000 | 39,100 | 76.82% |
| Dec 31, 1999 | 50,900 | 4,500 | 9.70% |
| Dec 31, 1998 | 46,400 | -2,800 | -5.69% |
| Dec 31, 1997 | 49,200 | 2,700 | 5.81% |
| Dec 31, 1996 | 46,500 | 2,700 | 6.16% |
| Dec 31, 1995 | 43,800 | 3,000 | 7.35% |
| Dec 31, 1994 | 40,800 | 300 | 0.74% |
| Dec 31, 1993 | 40,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Merck & Co. | 75,000 |
| Sanofi | 74,846 |
| Novo Nordisk | 69,505 |
| GSK plc | 68,629 |
| AbbVie | 57,000 |
PFE News
- 4 hours ago - 5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (March 2026) - Seeking Alpha
- 1 day ago - Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies - Seeking Alpha
- 1 day ago - China approves Pfizer GLP-1 drug for weight management - Reuters
- 1 day ago - Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund - Reuters
- 3 days ago - Seven S&P500 Ideal 'Safer' March Dividend Dogs - Seeking Alpha
- 3 days ago - Pfizer's Portfolio Renewal In Progress - High Yields For The Patient - Seeking Alpha
- 3 days ago - NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals - PRNewsWire
- 4 days ago - Pfizer's Quiet Cash Comeback - Seeking Alpha